Iovance Biotherapeutics, Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · San Carlos, CA
IOVA chart
What traders are saying about $IOVA
Latest postsIovance Biotherapeutics, Inc. news
- Form SCHEDULE 13G IOVANCE BIOTHERAPEUTICS, Filed by: STATE STREET CORP
StreetInsider ·
- Iovance Biotherapeutics (IOVA): The Growth Story Gathers Steam, But Can The Stock Turn The Tide?
RTTNews ·
- Barclays, Deutsche Bank Reveal Stakes In Retail-Favorite Cancer Stocks SLS, IBRX And IOVA — Geode Adds More
stocktwits.com ·
- Iovance Biotherapeutics, Inc. (IOVA) stock price, news, quote and history
Yahoo Finance Singapore ·
- Iovance Biotherapeutics (IOVA) Q3 Earnings Sharpen Focus On Margin Recovery
Yahoo Finance ·
- Iovance Biotherapeutics (IOVA) Stock Edges Higher After Q3 Earnings Progress
Simply Wall St ·
- Iovance Biotherapeutics, Inc. 2026 Q3 - Results - Earnings Call Presentation (NASDAQ:IOVA) 2026-11-06
Seeking Alpha ·
- Iovance Biotherapeutics Stock Price Forecast. Should You Buy IOVA?
StockInvest.us ·
- Iovance Biotherapeutics, Inc. (IOVA) Company Profile & Facts - Yahoo Finance
Yahoo! Finance Canada ·
- Citizens maintains Iovance Biotherapeutics at Market Outperform, raises price target to $12 from $8
TradingView ·
- Iovance Biotherapeutics shares drop 46% after v...
Pluang ·
- Iovance Biotherapeutics posts 80% revenue growt...
Pluang ·
Iovance Biotherapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $263.5M | $164.1M | $1.2M | – |
| Net income | -$391.0M | -$372.2M | -$444.0M | -$395.9M |
| Diluted EPS | $-1.09 | $-1.28 | $-1.89 | $-2.49 |
| Total assets (year end) | $913.2M | $910.4M | $780.4M | $664.0M |
| Cash and equivalents (year end) | $163.1M | $115.7M | $114.9M | $231.7M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Iovance Biotherapeutics, Inc.
- Ticker
- IOVA (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- San Carlos, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1425205
- Former names
- Lion Biotechnologies, Inc., Genesis Biopharma, Inc, FREIGHT MANAGEMENT CORP
Frequently asked questions
What exchange is Iovance Biotherapeutics, Inc. listed on?
Iovance Biotherapeutics, Inc. trades on the Nasdaq under the ticker symbol IOVA.
What industry is Iovance Biotherapeutics, Inc. in?
Iovance Biotherapeutics, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Iovance Biotherapeutics, Inc. headquartered?
Iovance Biotherapeutics, Inc.'s business address on file with the SEC is in San Carlos, CA.
When does Iovance Biotherapeutics, Inc.'s fiscal year end?
Iovance Biotherapeutics, Inc.'s fiscal year ends on December 31.
How much revenue did Iovance Biotherapeutics, Inc. report?
Iovance Biotherapeutics, Inc. reported $263.5M in revenue for calendar year 2025, according to its SEC filings.